{
    "clinical_study": {
        "@rank": "70370", 
        "acronym": "FMRICH", 
        "arm_group": [
            {
                "arm_group_label": "Fluoxetine", 
                "arm_group_type": "Experimental", 
                "description": "fluoxetine per os 20 mg daily"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "per os daily"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a randomized, double-blind, placebo-controlled, multicenter clinical trial that will\n      be carried out in Mexico. The purpose of this study is to test whether a 3-month treatment\n      with fluoxetine enhances motor recovery in non-depressed patients with acute intracerebral\n      hemorrhage."
        }, 
        "brief_title": "Fluoxetine for Motor Recovery After Acute Intracerebral Hemorrhage", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Intracerebral Hemorrhage", 
            "Motor Impairment"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hemorrhage", 
                "Cerebral Hemorrhage"
            ]
        }, 
        "detailed_description": {
            "textblock": "Spontaneous, nontraumatic intracerebral hemorrhage (ICH) is a subtype of stroke that causes\n      a great amount of disability, economic and social burden. This is particularly true in\n      developing countries where it accounts for between 20% and 50% of all strokes.\n      Pharmacological and surgical interventions have been attempted to diminish the mortality and\n      disability derived from ICH, with unsuccessful results. Recently the use of Fluoxetine in\n      addition to physical rehabilitation has been proven useful to improve motor recovery from\n      cerebral infarct. The purpose of this study is to test whether a 3-month treatment with\n      fluoxetine enhances motor recovery in non-depressed patients with acute intracerebral\n      hemorrhage.\n\n      This is a randomized, double-blind, placebo-controlled, multicenter clinical trial. This\n      trial will recruit 86 patients with intracerebral hemorrhage of both sexes, ages >18 years,\n      from four Mexican hospitals. The patients will receive either 20mg of fluoxetine or a\n      placebo once daily for 90 days. The primary outcome is the mean change in Fugl-Meyer Motor\n      Scale score between inclusion (day 0) and day 90. The secondary outcomes will be changes in\n      Barthel Index, Modified Rankin scale and National Institutes of Health (NIH) Stroke Scale.\n      The outcomes will be measured at day 45\u00b17days and at day 90, for a total of four visits with\n      each subject (at screening and at 0, 45 and 90days)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients who had an acute intracerebral hemorrhage within the past 10 days causing\n             hemiparesis or hemiplegia\n\n          -  Fugl-Meyer motor scale (FMMS) scores of 55 or less\n\n          -  Written informed consent for participation in the trial\n\n        Exclusion Criteria:\n\n          -  Severe post-stroke disability (National Institutes of Health stroke scale [NIHSS]\n             score >20)\n\n          -  Premorbid disability, evidenced by residual motor deficit from a previous stroke\n\n          -  Comprehension deficit or severe aphasia\n\n          -  Previous diagnosis of depression or one of the following:\n\n               -  Hospital Anxiety and Depression Scale score \u226511 points\n\n               -  Taking antidepressant drugs two weeks before inclusion\n\n          -  Taking neuroleptic drugs or benzodiazepines two weeks before inclusion\n\n          -  Other major diseases with life expectancy less than 3 months."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "86", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 21, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01737541", 
            "org_study_id": "83/11"
        }, 
        "intervention": [
            {
                "arm_group_label": "Fluoxetine", 
                "intervention_name": "Fluoxetine", 
                "intervention_type": "Drug", 
                "other_name": "Fluoxac"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Fluoxetine", 
                "Serotonin Uptake Inhibitors"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cerebrovascular Disorders", 
            "Cardiovascular Diseases", 
            "Intracerebral Hemorrhage", 
            "Serotonin Uptake Inhibitors", 
            "Therapeutic Uses"
        ], 
        "lastchanged_date": "February 11, 2014", 
        "location": [
            {
                "contact": {
                    "email": "jorulej-lnj@prodigy.net.mx", 
                    "last_name": "Jos\u00e9 L Ruiz-Sandoval, MD", 
                    "phone": "+52 3339424400"
                }, 
                "facility": {
                    "address": {
                        "city": "Guadalajara", 
                        "country": "Mexico", 
                        "state": "Jalisco", 
                        "zip": "44280"
                    }, 
                    "name": "Antiguo Hospital Civil de Guadalajara Fray Antonio Alcalde"
                }, 
                "investigator": {
                    "last_name": "Jos\u00e9 L Ruiz-Sandoval, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "erdelacres@yahoo.com.mx", 
                    "last_name": "Erik de-la-Cruz-Estrada, MD", 
                    "phone": "+529933100300"
                }, 
                "facility": {
                    "address": {
                        "city": "Villahermosa", 
                        "country": "Mexico", 
                        "state": "Tabasco", 
                        "zip": "86126"
                    }, 
                    "name": "Hospital Regional de Alta Especialidad Dr. Juan Graham Casasus"
                }, 
                "investigator": {
                    "last_name": "Erik de-la-Cruz-Estrada, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "scint1st@gmail.com", 
                    "last_name": "Juan M Marquez, MD", 
                    "phone": "+524499108436", 
                    "phone_ext": "8436"
                }, 
                "facility": {
                    "address": {
                        "city": "Aguascalientes", 
                        "country": "Mexico", 
                        "zip": "202301"
                    }, 
                    "name": "Hospital General de Zona #1"
                }, 
                "investigator": {
                    "last_name": "Juan M Marquez-Romero, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "antonio.arauz@prodigy.net.mx", 
                    "last_name": "Angel A Arauz, PhD", 
                    "phone": "+52 55 51710890"
                }, 
                "facility": {
                    "address": {
                        "city": "Mexico City", 
                        "country": "Mexico", 
                        "zip": "14269"
                    }, 
                    "name": "Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda"
                }, 
                "investigator": {
                    "last_name": "Angel A Arauz, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Mexico"
        }, 
        "number_of_arms": "2", 
        "official_title": "Fluoxetine for Motor Recovery After Acute Intracerebral Hemorrhage (FMRICH): a Randomised Placebo-controlled Trial", 
        "overall_contact": {
            "email": "scint1st@gmail.com", 
            "last_name": "Juan M Marquez-Romero, MD", 
            "phone": "+524499108436", 
            "phone_ext": "8436"
        }, 
        "overall_official": [
            {
                "affiliation": "Universidad Aut\u00f3noma de Aguascalientes", 
                "last_name": "Juan M Marquez-Romero, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda", 
                "last_name": "Angel A Arauz, PhD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Mexico: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Change from Baseline in Fugl Meyer Motor Scale score at 90 days", 
            "measure": "Fugl Meyer Motor Scale score", 
            "safety_issue": "No", 
            "time_frame": "Baseline and 90 days"
        }, 
        "reference": {
            "PMID": "23510124", 
            "citation": "Marquez-Romero JM, Arauz A, Ruiz-Sandoval JL, Cruz-Estrada Ede L, Huerta-Franco MR, Aguayo-Leytte G, Ruiz-Franco A, Silos H. Fluoxetine for motor recovery after acute intracerebral hemorrhage (FMRICH): study protocol for a randomized, double-blind, placebo-controlled, multicenter trial. Trials. 2013 Mar 19;14:77. doi: 10.1186/1745-6215-14-77."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01737541"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Universidad Aut\u00f3noma de Aguascalientes", 
            "investigator_full_name": "Juan Manuel Marquez-Romero", 
            "investigator_title": "Profesor Investigador", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Change from Baseline in Barthel Index at 90 days", 
                "measure": "Barthel Index", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 90 days"
            }, 
            {
                "description": "Change from Baseline in modified Rankin Scale at 90 days", 
                "measure": "modified Rankin Scale", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 90 days"
            }, 
            {
                "description": "Change from Baseline in NIH Stroke Scale at 90 days", 
                "measure": "NIH Stroke Scale", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 90 days"
            }
        ], 
        "source": "Universidad Aut\u00f3noma de Aguascalientes", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Universidad Aut\u00f3noma de Aguascalientes", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}